Trent P McLaughlin

Suggest Changes
Learn More
BACKGROUND & AIMS The clinical impact of nonadherence to gastroprotective agents (GPAs) coprescribed with anti-inflammatory therapies has not been evaluated. In a large, commercial, managed-care(More)